Mutant fatty acid desaturase

ABSTRACT

The present invention relates to a method for producing mutants of a fatty acid desaturase having a substantially increased activity towards fatty acid substrates with chains containing fewer than 18 carbons relative to an unmutagenized precursor desaturase having an 18 carbon atom chain length substrate specificity. The method involves inducing one or more mutations in the nucleic acid sequence encoding the precursor desaturase, transforming the mutated sequence into an unsaturated fatty acid auxotroph cell such as MH13  E. coli , culturing the cells in the absence of supplemental unsaturated fatty acids, thereby selecting for recipient cells which have received and which express a mutant fatty acid desaturase with an elevated specificity for fatty acid substrates having chain lengths of less than 18 carbon atoms. A variety of mutants having 16 or fewer carbon atom chain length substrate specificities are produced by this method. Mutant desaturases produced by this method can be introduced via expression vectors into prokaryotic and eukaryotic cells and can also be used in the production of transgenic plants which may be used to produce specific fatty acid products.

[0001] The present application is a continuation-in-part of U.S. patent application Ser. No. 09/233,856 filed on Jan. 19, 1999.

[0002] This invention was made with Government support under contract number DE-AC02-98CH10886, awarded by the U.S. Department of Energy. The Government has certain rights in the invention.

BACKGROUND OF THE INVENTION

[0003] Fatty acid biosynthesis in higher plants has recently attracted increased interest because of the possible use of plant oils as renewable sources for reduced carbon. The diversity of fatty acid forms in wild plants is vast compared to that of crop plants. This diversity is reflected in the variations in chain length, the number and position of double bonds, and the position and occurrence of a variety of other functional groups in the fatty acids of wild plants.

[0004] In plants, fatty acid biosynthesis occurs in the chloroplasts of green tissue or in the plastids of non-photosynthetic tissues. The primary products in most plants are acyl carrier protein (ACP) esters of the saturated palmitic (palmitoyl-ACP) and/or stearic (stearoyl-ACP) acids, palmitic acid having a 16 carbon atom chain length and stearic acid having an 18 carbon atom chain length. Two types of desaturase molecules are involved in the production of monounsaturated fatty acids (monoenes), soluble, and integral membrane proteins. Desaturases are specific for a particular substrate carbon atom chain length (chain length specificity) and introduce the double bond between specific carbon atoms in the chain (double bond positional specificity) by counting from the carboxyl end of the fatty acid. For instance, the castor Δ⁹-18:0 desaturase is specific for stearoyl-ACP, and introduces a double bond between carbon atoms 9 and 10.

[0005] The introduction of non-native desaturase isoforms having unique characteristic chain length and double bond positional specificities into agricultural crops offers a way to manipulate the content, physical properties and commercial uses of plant-produced oils. Unfortunately, the introduction of non-native acyl-ACP desaturase isoforms into agricultural crop plants has yet to lead to the efficient production of unusual monoenes by agricultural crop plants. An alternative way in which to accomplish the manipulation of the content, physical properties and commercial uses of oilseed crops would be through the introduction of a native desaturase which had been manipulated in such a way as to alter its chain length and/or double bond positional specificities.

[0006] As the genes encoding more desaturase enzymes are identified it is becoming apparent that many of the different activities are derived from relatively few common archetypes encoding the soluble and membrane classes of desaturases. Molecular modeling and X-ray crystallographic studies of soluble acyl-ACP desaturases have identified amino acid residues within the substrate binding channel which are in very close proximity to the fatty acid substrate. Such residues are referred to as “contact residues”. That earlier research demonstrated that certain modifications of one or more contact residues and modification of some non-contact residues can alter the chain-length and double bond positional specificities of acyl-ACP desaturases in vitro (Cahoon, et al. Proc. Natl. Acad. Sci. USA (1997) 94:4872-4877 and Cahoon, et al. U.S. Pat. Nos. 5,705,391, 5,888,790 and 6,100,091). Those studies were carried out using predictions formulated from the three dimensional structure of the castor Δ⁹-18:0 acyl-ACP desaturase in combination with alignment of its sequence with that of a Δ⁶-16:0 acyl-ACP desaturase as well as with the sequences of other 18:0 desaturases. The studies examined the effects of replacing specific contact and non-contact amino acid residues of one enzyme with the amino acid in the cognate position of the other enzyme on the in vitro substrate chain length and double bond positional specificities of several desaturase enzymes. The studies demonstrated that substituting a major portion of the substrate binding channel of a Δ⁹-18:0 desaturase into the homologous position of a Δ⁶-16:0 desaturase converted its in vitro specificity to that of a Δ⁹-18:0 desaturase. This could also be accomplished by replacing five specific amino acids of the Δ⁶-16:0 desaturase with five amino acids of the Δ⁹-18:0 desaturase which occupy homologous positions. It was also shown that substituting bulky amino acids (isoleucine for proline at position 179 and phenylalanine for leucine at position 118) into the substrate binding channel of the Δ⁹-18:0 desaturase increased its preference for the 16:0-ACP substrate such that the in vitro 16:0-ACP activity became slightly more than two-fold greater than its remaining 18:0-ACP activity.

[0007] The ability to manipulate the chain length and double bond position specificities of desaturases has great potential with regard to generation and use of mutated native desaturases in the production of commercially useful products, such as vegetable oils rich in monounsaturated fatty acids. Such vegetable oils are important in human nutrition. In addition, because a double bond in an otherwise saturated carbon chain is readily susceptible to chemical modification, fatty acid chains having double bonds in unique positions produced by crop plants can be useful raw materials for industrial processes.

[0008] The earlier studies making use of molecular modeling and crystallographic data, while successful, were extremely time consuming and the in vitro activity of the altered enzymes was not directly correlated to the in vivo specificities of the altered enzymes. Those studies pointed out a need for a simplified and general method for readily producing mutants of desaturases which have altered and desirable chain length and double bond positional specificities.

SUMMARY OF THE INVENTION

[0009] The present invention relates to a simple and general method for producing a mutant of a fatty acid desaturase, the original desaturase having an 18 carbon atom chain length substrate specificity, the mutant produced having substantially increased activity relative to the original desaturase towards fatty acid substrates with chains containing fewer than 18 carbons. The method involves inducing one or more mutations in the nucleic acid sequence encoding the original desaturase, transforming the mutated nucleic acid sequence under conditions for expression into a cell which normally requires a growth medium that is supplemented with unsaturated fatty acids in order to proliferate (i.e., an unsaturated fatty acid auxotroph cell), and then selecting for recipient cells which have received a mutant fatty acid desaturase with a specificity for shorter carbon atom chain length substrates. In a preferred embodiment, the mutated nucleic acid sequences are transformed into an E. coli unsaturated fatty acid auxotroph designated MH13. The cells are then grown in the absence of added unsaturated fatty acids to select for recipient MH13 cells which express mutated enzymes which are capable of producing sufficient unsaturated fatty acids in the cell to support growth, thereby overcoming the auxotrophy. Other aspects of the present invention include the mutants which are produced. Mutants of castor Δ⁹-18:0-ACP desaturase produced by the method arise from amino acid substitutions at specific residues. These mutants each have altered substrate chain length specificity, of 16- or fewer carbon atoms. Other embodiments of the present invention encompass the expression of the mutant desaturase molecules in individual cells and also in transgenic plants, for the production of specific fatty acid products.

BRIEF DESCRIPTION OF THE DRAWINGS

[0010]FIG. 1 lists the amino acid sequence (SEQ ID NO: 1) of mature Δ⁹-18:0-ACP castor desaturase enzyme.

DETAILED DESCRIPTION OF THE INVENTION

[0011] The present invention is based on the use of a bacterial selection system for the selection of mutant desaturase molecules which have 18-carbon atom chain length substrate specificities prior to the introduction of the mutation and which have a 16 or fewer carbon atom chain length substrate specificity of as a result of the mutation. A preferred bacterial strain used in the selection system, E. coli MH13, is an unsaturated fatty acid auxotroph. MH13 normally requires a growth medium that is supplemented with unsaturated fatty acids in order to proliferate. Previous research (Cahoon, et al., (1996) J. Bacteriology 178:936-939 and Thompson, et al. (1991) Proc. Natl. Acad. Sci. USA 88:2578-2582) demonstrated that although 14:0 and 16:0 acyl-ACP desaturases were able to use in vivo pools of acyl-ACPs in E. coli to produce monounsaturated fatty acids, Δ⁹-18:0 acyl-ACP desaturases do not generate detectable amounts of monounsaturated fatty acids when expressed in E. coli. Thus, due to the substrate pools of saturated fatty acid substrates in E. coli, the Δ⁹-18:0 desaturase enzymes are not sufficiently active in the E. coli host cell and are thus not able to complement the deficiency in unsaturated fatty acid auxotrophs such as E. coli MH13. Desaturase enzymes which specifically utilize 18-carbon chain length substrates cannot complement the auxotrophy due to the low levels of such 18-carbon chain length substrates in the bacterial cell. However, introduction of a functional desaturase enzyme which has substantial activity towards fatty acid substrates with chains containing 16 or fewer carbons will complement this auxotrophy, allowing for the growth and proliferation of the bacteria in the absence of supplemental unsaturated fatty acids. These observations have been exploited as a selection system for identifying mutants of an 18-carbon specific fatty acid desaturase which have a substantially increased activity towards fatty acid substrates with chains containing 16 carbons or 14 carbons. While E. coli MH13 is a preferred host cell, one of skill in the art will recognize that other host cell types may be employed.

[0012] The present invention provides for a method of producing a mutant of a fatty acid desaturase, the mutant being characterized as having a specificity for shorter chain length fatty acid substrates compared to the original fatty acid desaturase. The method requires nucleic acid sequences encoding a fatty acid desaturase with 18 carbon atom chain length substrate specificity. To produce the mutant, mutations are induced in the nucleic acid sequence encoding the fatty acid desaturase. The mutated nucleic acid sequence is then transformed into the MH13 E. coli cells under conditions appropriate for expression of the mutated sequence. The transformed MH13 E. coli cells are then selected for the ability to grow in the absence of supplemental unsaturated fatty acids. Survival of a transformed MH13 E. coil indicates the acquisition of a mutant fatty acid desaturase which complements the fatty acid auxotrophy of MH13 because of its altered chain length specificity. A mutant fatty acid desaturase identified by the above selection assay has a substantial increase in the activity towards fatty acid substrates with chains containing fewer than 18 carbons, relative to the original desaturase. A substantial increase in substrate specificity with respect to the original desaturase is one that produces sufficient accumulation of unsaturated fatty acids, which results from desaturation by the mutant desaturase, within an unsaturated fatty acid auxotroph host organism so as to support growth and proliferation of the host organism. Substantial increase in activity sufficient to support growth of the auxotroph host is at least three-fold higher than that of the non-mutagenized precursor desaturase. In a preferred embodiment, the increase in activity of the mutant desaturase is at least ten-fold higher than the non-mutagenized precursor desaturase.

[0013] The Exemplification section below details experiments where the method was used to identify mutants of castor Δ⁹-18:0-ACP desaturase with modified substrate specificities. One of skill in the art will recognize that the method is suitable for producing mutants of any fatty acid desaturase which has an 18 carbon atom chain length substrate specificity prior to mutagenesis. To do so requires only a nucleic acid sequence for the desaturase. Expression of the nucleic acid sequence results in the production of a mature fatty acid desaturase, and following mutagenesis of the nucleic acid sequence, those sequences which are mutated to cause the alteration in the chain length specificity of enzyme will be expressed and identified through the selection procedure.

[0014] The nucleic acid sequences having silent mutations which do not affect the amino acid sequence of the translated product would not be identified in the selection procedure. Nucleic acid sequences encoding a functional fatty acid desaturase, whose amino acid sequence varies from wild type, for example with conservative amino acid substitutions that do not affect function in regard to carbon chain length substrate specificity would also not be identified in the selection procedure. However, such mutated desaturases may be desirable when incorporating several different functional mutations into one mutant.

[0015] In preferred embodiments, the fatty acid desaturase is a plant fatty acid desaturase. There are two types of plant fatty acid desaturases, soluble (acyl-ACP desaturases), and integral membrane (acyl lipid desaturases), both of which are suitable for use in the present invention.

[0016] In one embodiment, the MH3 E. coli also express an exogenous plant ferredoxin. This can be accomplished by introduction of an expression vector containing sequences which encode plant ferredoxin (e.g. Arabaena vegetative ferredoxin), and the application of selective pressure to the resulting bacteria. The presence of plant ferredoxin, the redox partner of the plant desaturases, facilitates the function of the plant desaturase in E. coli. The presence of plant ferredoxin in the selection system allows for the selection of mutants with low specific activities towards fatty acids with 16 or fewer carbon atoms. Mutants which complement MH13 in the absence of plant ferredoxin are expected to have comparatively higher specific activities toward the shorter fatty acid substrates (Cahoon, et al. (1996)).

[0017] The selection system described above is most appropriate for use in selecting mutants with the desired substrate specificity from a population of heterogenous mutant fatty acid desaturase molecules. By transforming a population of mutated nucleic acid sequences, entire libraries of mutants can be screened for the ability complement the MH13 auxotrophy.

[0018] Any type of mutation which has the potential to result in a modified fatty acid desaturase protein product can be induced in the nucleic acid sequences. Logic based approaches of introducing amino acid substitutions into residues which interact with substrate are sound but can be very labor intensive and are mainly suited to cases in which structural information is available. Such methods have been successfully employed for modifying the chain length specificity of soluble desaturases, and for the introduction of double-bond versus hydroxyl group for the membrane class of enzymes (Cahoon et al., (1997); Shanklin, et al. (1998) Annu. Rev. Plant Physiol. Plant Mol Biol. 49:611-641). Experiments described in the Exemplification section which follows demonstrate a form of site directed mutagenesis which specifically targets a particular codon, or codons, to produce amino acid randomization at specific position(s) within the protein product. These experiments also describe utilization of random mutagenesis, which has the potential to identify additional amino acids involved in substrate specificity. The use of random mutagenesis is perhaps the most powerful method because it does not rely on assumptions about which residues are important, assumptions which are based on structural information. The present method has the ability to identify substitution mutations at positions which are amino acid contact residues (positions which are located nearest the substrate within the binding channel) and also positions which affect the substrate specificity without directly contacting the substrate (Cahoon et al., (1997)).

[0019] Once mutated, the nucleic acid sequences are transformed into the MH13 cells. Transformation is preferably accomplished by electroporation, but alternative methods known to one of skill in the art can also be used.

[0020] Following transformation, the cells are selected for the presence of the mutant fatty acid desaturase. This is accomplished by growth on selective media (e.g. media which is not supplemented with unsaturated fatty acids). The media can be either solid or liquid. Using several rounds of selection, and/or varying or augmenting the selective pressures involved is also useful in increasing the number of mutants identified by the method.

[0021] The present invention is useful in the engineering of desaturase proteins with characteristic substrate chain length preferences. Such isoforms, when introduced into cells or organisms, (e.g. agricultural crops) can be used to manipulate the physical properties and commercial uses of conventional plant oils. Cells and organisms which express these engineered desaturases are useful in the production of commercially useful products, such as vegetable oils rich in monounsaturated fatty acids, which have many potential uses, for example in human nutrition or as industrial chemicals.

[0022] The Exemplification section below details experiments where the above described method was used to identify mutants of castor Δ⁹-18:0-ACP desaturase with modified substrate specificities. Mutations which result in amino acid substitutions at position 114, 117, 118, 179, 181, or 188, and combined substitutions at positions 114 and 188 are described, along with the resulting change in specificity of these mutant proteins compared to wild type. The listed amino acid substitutions made at the analogous positions in other ACP-desaturases, especially in 18:0-ACP desaturases, and preferably in Δ⁹-18:0-ACP desaturases, are predicted to have the analogous effects on substrate specificity.

[0023] The mutants produced can be inserted into a DNA expression vector, which can be used to express the mutants in cells. Expression vectors which function in either and/or both prokaryotic and eukaryotic cells exist and are known to those of skill in the art. The appropriate expression vectors are introduced into either prokaryotic cells (e.g. bacteria) and also eukaryotic cells (e.g. animal cells or plant cells) to promote expression of the mutant proteins. Plant cells which express the mutant proteins can be used to produce transgenic plants which express the mutant proteins, and which produce the corresponding fatty acid products of the desaturases.

Exemplification

[0024] A mutagenesis and selection approach was employed to identify amino acid substitution mutations in fatty acid desaturases which modify substrate specificity. Acyl-ACP desaturases are functionally active when expressed in E. coli. Δ⁹-18:0-ACP desaturases are unable to alter the fatty acid profile of E. coli due to a lack of appropriate substrate (Thompson et al., (1991)). However, desaturases with 16:0 or 14:0 specificity were shown to alter the fatty acid profile of E. coli (Cahoon, et al. (1996)). Thus, 18:0 desaturases cannot complement the E. coli mutant MH13, an unsaturated fatty acid auxotroph, but desaturases with specificities for fatty acids with 16 or fewer carbons are able to complement this auxotrophy. Thus, the MH13 E. coli strain was used to select for mutants of an 18-carbon atom-specific desaturase which can utilize 16- or 14-carbon atom substrates in a complementation assay.

[0025] To facilitate the function of a plant acyl-ACP desaturase in E. coli, an expression vector containing the gene for plant ferredoxin, the redox partner of the plant desaturase, was transformed into the MH13 E. coli and maintained under selective pressure. These cells, MH13(pACYC/LacAnFd), were used in the following experiments.

[0026] The nucleic acid sequence for castor Δ⁹-18:0-ACP desaturase was subjected to one of two types of mutagenesis, site directed or random mutagenesis, prior to introduction into the MH13 cells. PCR was used in site directed mutagenesis to randomize a targeted codon corresponding to a specified residue in the amino acid sequence of the castor-Δ⁹-18:0-ACP desaturase. Target codons corresponding to Met 114, Leu 118, Pro 179, and Gly 188 were each subjected to independent randomization. Previous studies (Cahoon, et al. (1997)) had indicated that these residues are located adjacent to the substrate binding cavity and that replacing some of those amino acids in the T. alata Δ ⁶-16:0 desaturase or in the castor Δ⁹-18:0 desaturase with bulkier or less bulky amino acids could affect substrate specificity in vitro. The methods of the present invention allowed for an unbiased substitution of all 20 amino acids into these to positions but required that the mutation have an affect on the in vivo substrate specificity of the desaturase. The mutagenesis reactions yielded four populations, each one comprising a library of coding sequences with substitution mutations consisting of all 20 potential amino acids at the designated mutation site.

[0027] To examine whether mutations in additional contact and or non-contact amino acid residues could alter the in vivo substrate specificity of the castor Δ⁹-18:0 desaturase, a totally unbiased approach using random mutagenesis was performed on sequences encoding castor Δ⁹-18:0-ACP desaturase by single gene DNA shuffling.

[0028] MH13 (pACYC/LacAnFd) were transformed with the resulting libraries of mutated 18:0-ACP desaturase nucleic acid sequences, under conditions appropriate for expression, and then selected for expression of a mutant with the ability to complement the unsaturated fatty acid auxotrophy, by growth in the absence of supplemental unsaturated fatty acid. To confer survival under the selective conditions, a mutant desaturase would necessarily have an altered substrate chain length specificity of 16, 14 or fewer carbons. The selection for site directed mutants was performed in either liquid media or on agar plates. The selection for randomly generated mutants was performed on agar plates. Growth in liquid media involved several rounds of dilution and re-growth to enrich for mutations that resulted in the best complementation.

[0029] In a variation on the site directed mutagenesis, mutants were selected from a library encoding all 400 possible combinations of amino acids at position 188 and 114, two adjacent contact residues within the substrate binding channel. This was achieved by excising a restriction fragment from the open reading frame of the library encoding all possible amino acids at position 188 and inserting this fragment into the equivalent plasmid population randomized for position 114. Using this method, mutant M114I-G188L was identified in the selection procedure. The coding sequences of the selected desaturases were sequenced to identify the specific mutations which conferred complementation to the fatty acid auxotrophy. The substrate specificities of the identified mutants were determined by in vitro enzyme assays (Cahoon et al., (1997)). Table 1 lists the identified mutations and the altered chain length substrate specificity conferred. TABLE 1 Fold change in specificity Mutagenesis method with respect to wt Position Directed Random 16:18 14:18 Met 114 Ile (16) Ile (16) 6 Met 114 Phe (14)/ Phe 7 490 Tyr (14) Thr 117 Ile (16) not determined Leu 118 Phe (16)/ Phe (16)/ Tyr 130 Tyr (16) Met (16) Pro 179 Ile (16) Leu (14) 20 Thr 181 Ile (16) not determined Gly 188 Leu (16) 740 Met 114-Gly188: M114I-G188L (16) 1410 # decreased by 5-fold, the “Fold change in specificity with respect to wt”for 16:18 would be 50.

[0030] The designated amino acid positions above correspond to the mature castor enzyme as defined in Lindqvist et al., EMBO J 15:4081-4092 (1996), the sequence (SEQ ID NO: 1) of which is listed in FIG. 1.

[0031] While the use of structure-guided (i.e., directed) mutagenesis of residues M114, L118, 2170 and G188 was effective for the identification of seven mutants with substrate specificities of 16 or fewer carbons, the method relied on the appropriate choice of target residues for mutagenesis. It is well documented that residues that affect substrate specificity fall into two broad classes, direct and indirect. Thus, random mutagenesis selection provides a bias-free method for the identification of changes that result in increased specificity for shorter acyl chains. Through random mutagenesis and selection, five amino acid positions were identified, three at sites that were also targets for the structure-guided mutagenesis, and two new sites, T117 and T181, were identified.

[0032] Naturally occurring 16:0-ACP desaturases from Milkweed and Doxantha have very poor activities when assayed in vitro (31 and 3 nM/min/mg, respectively). By comparison, the selected mutant G188L has an activity of (175 nM/min/mg), much closer to that of the parental wild type castor Δ⁹-18:0-ACP desaturase for its 18:0-ACP substrate.

[0033] To test whether the altered enzymes identified in the selection assay would result in the accumulation of unusual fatty acids when expressed in plants, the G188L mutant was introduced into Arabidopsis thaliana (fab1 background) using a napin promoter to drive expression. The first generation of G188L transgenics (T1) produced seeds which contained approximately 10% of fatty acids modified by the introduced desaturase. Because T1 seeds are heterozygous it is anticipated the levels of desired fatty acids will increase in the homozygous T2 plants. These results suggest that mutants derived from castor Δ⁹-18:0-ACP desaturase may be useful for future metabolic engineering of oil crops.

Methods of the Invention

[0034] Cell lines. The E. coli unsaturated fatty acid auxotroph MH13 mutant of E. coli K12 (Henry, M. F., Ph.D. Thesis (1992) University of Illinois, Urbana-Champaign) is a fadR::Tn5 mutant of cell line DC308 (Clark et al. (1983) Biochemistry 22:5897-5902) which was constructed by phage P1 transduction from strain RS3069 (Simons et al. (1980) J. Bacteriol. 142:621-632). MH3 requires a medium supplemented with unsaturated fatty acids at all growth temperatures due to a temperature-sensitive lesion in fabA and transposon disruption of fadR. An XbaI/EcoRI fragment from a pET9d expression plasmid containing the coding sequence of Anabaena vegetative ferredoxin (Fd) (Cheng et al. (1995) Arch. Biochem. Biophys. 316: 619-634) was inserted into the corresponding sites of pLac3d to generate the plasmid pLacAnFd. pLac3d is analogous to pET3d except that the T7 RNA polymerase promoter has been replaced with the lacUV5 promoter of E. coli RNA polymerase as described previously (Cahoon et al. (1996)). A BglII/HindIII fragment from pLacAnFd was then inserted into the BamHI/HindIII sites of pACYC184. This construct (pACYC/LacAnFd) was then introduced into MH13 cells by electroporation.

[0035] Complementation Analysis/Selection. The E. coli MH13 strain harboring pACYC/LacAnFd was used as a host for expression of acyl-ACP desaturases. For these studies, the coding sequence of wild type and mutant mature acyl-ACP desaturases were inserted into pLac3d. Cells were transformed with the resulting plasmid constructs and were then grown on plates or in liquid broth containing Luria-Bertani (LB) media with ampicillin (100 μg/ml), chloramphenicol (35 μg/ml), and kanamycin (40 μg/ml) selection. For non-selective growth, plates were supplemented with the fatty acid oleic acid solubilized in Tergitol NP-40 (Sigma) with final concentrations of 250 μg/ml oleic acid and 2% (v/v) Tergitol. Liquid broth was supplemented with oleic acid (solubilized in Tergitol NP-40) at a final concentration of 100 μg/ml. Oleic acid was initially prepared as 1000×stock solution in ethanol and solubilized in melted Tergitol, prior to addition to the media. Media used to test for complementation of the auxotrophy did not contain added oleic acid, and IPTG was added at a concentration of 0.4 mM to induce expression of acyl-ACP desaturase from the expression vector.

[0036] Transformation. Transformation was conducted by electroporation using a 50 μl aliquot of competent MH13 cells harboring pACYC/LacAnFd and 0.1 to 0.5 μg of expression plasmid for a given acyl-ACP desaturase. Following electroporation, cells were resuspended in 500 μl of LB media and shaken (250 rpm) at 37° C. for 45 min to 1 h. Cells were then plated on media as described above. Alternatively, a 75 μl aliquot of the transformed cells was added to 25 ml of LB media containing IPTG and antibiotics at concentrations described above. These cells were then maintained with shaking at 30° or 37° C.

[0037] Electrocompetent MH13 (pACYC/LacAnFd) were prepared by growing a culture from a single colony in low-salt LB media (10 mg/ml Bacto tryptone, 5 mg/ml yeast extract, and 5 mg/ml sodium chloride) containing kanamycin (40 μg/ml) and chloramphenicol (35 μg/ml) and supplemented with oleic acid (100 μg/ml) and 2% Tergitol (v/v). Cells were prepared for transformation and electroporated as described in the BioRad protocol for high efficiency electro-transformation of E. coli.

[0038] Mutagenesis. Two methods were used for mutagenesis. The first, site directed mutagenesis, randomized a target residue at a specific location in the amino acid sequence of the castor Δ⁹-18:0-ACP desaturase. Four target residues were chosen: Met 114, Leu 118, Pro 179, and Gly 188. PCR was used to generate four populations of DNA. Each population consisted of sequences encoding castor Δ⁹-18:0-ACP desaturase with a randomized codon for residue 114, 118, 179, or 188. Each of the four populations was generated using PCR site directed mutagenesis to produce DNA products having equimolar proportions of each of the four nucleotides at each position of the target codon. For each of the four randomized products, an oligonucleotide primer was synthesized which hybridized to sequences adjacent to the target codon, and contained a randomized codon in place of the target codon sequences, the primer population containing equimolar proportions of each of the four nucleotides G, A, T, and C at the three positions within the replacement codon. This primer was used in conjunction with a primer homologous to the 5′ terminus of the gene to amplify the gene segment between the two primer binding sites. A second overlapping fragment was then synthesized using PCR to amplify the remainder of the respective coding sequences of the four PCR reaction products. The fragments were then incorporated into larger gene fragments using overlap extension polymerase chain reaction (Ho, et al. (1989) Gene 77: 51-59). The gene fragments containing the randomized target codons were inserted into pLac3.

[0039] The second mutagenesis method introduced random mutations into the coding region sequence by digesting the castor Δ⁹-18:0-ACP desaturase coding region with DNase, and reassembling using PCR (W. P. Stemmer (1994) Proc Natl Acad Sci USA 91:10747-10751). The entire coding region was reinserted into pLac3 to make a library of pLac3-castor-Δ⁹-18:0-ACP desaturase genes with random mutations throughout the coding region. 

1. A method for producing a mutant of a fatty acid desaturase, comprising: a) providing a nucleic acid sequence encoding a fatty acid desaturase having an 18 carbon atom chain length substrate specificity; b) inducing mutations in the nucleic acid sequence of step a); c) transforming the mutated nucleic acid sequence of step b) into an appropriate host cell under conditions appropriate for expression; and d) selecting for transformed cells of step c) which express a mutant fatty acid desaturase having a substantial increase in activity towards fatty acid substrates with chains containing fewer than 18 carbons, relative to the fatty acid desaturase encoded by the nucleic acid sequence of step a).
 2. The method of claim 1 wherein the host cell of step c) is an unsaturated fatty acid auxotroph.
 3. The method of claim 2 wherein the fatty acid auxotroph is MH13 E. coli.
 4. The method of claim 3 wherein the mutant fatty acid desaturase is characterized by the ability to complement the fatty acid auxotrophy of the MH13 E. coli.
 5. The method of claim 3 wherein the MH13 E. coli fatty acid auxotroph expresses exogenous ferredoxin.
 6. The method of claim 5 wherein the exogenous ferredoxin is Arabaena vegetative ferredoxin.
 7. The method of claim 6 wherein the MH13 E. coli expressing Arabaena vegetative ferredoxin is MH13(pACYC/LacAnFd).
 8. The method of claim 1 wherein the fatty acid desaturase is a plant fatty acid desaturase.
 9. The method of claim 8 wherein the plant fatty acid desaturase is an integral membrane protein.
 10. The method of claim 9 wherein the integral membrane protein is an acyl lipid desaturase.
 11. The method of claim 8 wherein the plant fatty acid desaturase is a soluble protein.
 12. The method of claim 11 wherein the soluble plant fatty acid desaturase is an acyl-ACP desaturase.
 13. The method of claim 12 wherein the acyl-ACP desaturase is castor Δ⁹-18:0-ACP desaturase.
 14. The method of claim 1 wherein the mutant fatty acid desaturase catalyzes desaturation of 16-carbon atom fatty acids.
 15. The method of claim 1 wherein the mutant fatty acid desaturase catalyzes desaturation of 14-carbon atom fatty acids.
 16. The method of claim 1 wherein the mutant fatty acid desaturase catalyzes desaturation of 12-carbon atom fatty acids.
 17. The method of claim 1 wherein the mutant fatty acid desaturase catalyzes desaturation of 10-carbon atom fatty acids.
 18. The method of claim 1 wherein the mutations of step b) are induced by random mutagenesis.
 19. The method of claim 12 wherein the random mutations are induced in an acyl-ACP desaturase nucleic acid sequence.
 20. The method of claim 1 wherein the mutations of step b) are induced by site directed mutagenesis at one or more codons.
 21. The method of claim 12 wherein site specific mutations are induced in the acyl-ACP desaturase nucleic acid sequences by site directed mutagenesis at one or more codons.
 22. The method of claim 21 wherein one or more codons specific for amino acid contact residues are mutated.
 23. The method of claim 21 wherein one or more codons specific for amino acids which are not contact residues are mutated.
 24. The method of claim 1 wherein transformation is by electroporation.
 25. The method of claim 1 wherein selection is performed in liquid media.
 26. The method of claim 1 wherein selection is performed on solid media.
 27. The method of claim 3 wherein the mutated nucleic acid sequence is inserted into the expression vector pLac3 prior to transformation into the MH13 E. coli.
 28. A mutant 18:0-ACP desaturase which has a sufficiently elevated 16 carbon atom chain length substrate specificity, such that when introduced into an unsaturated fatty acid auxotroph cell said mutant desaturase permits growth of said unsaturated fatty acid auxotroph cell in an absence of supplemental unsaturated fatty acid.
 29. The mutant 18:0-ACP desaturase of claim 28 wherein the mutant 18:0-ACP desaturase is a mutant plant 18:0 desaturase.
 30. The mutant plant 18:0-ACP desaturase of claim 29 wherein the mutant plant 18:0-ACP desaturase is a mutant castor Δ⁹-18:0 desaturase.
 31. The mutant castor Δ⁹-18:0-ACP desaturase of claim 30 having an amino acid substitution of Ile for Met at residue 114 of SEQ ID NO:
 1. 32. The mutant castor Δ⁹-18:0-ACP desaturase of claim 30 having an amino acid substitution of Ile for Thr at residue 117 of SEQ ID NO:
 1. 33. The mutant castor Δ⁹-18:0-ACP desaturase of claim 30 having an amino acid substitution selected from the group Phe, Tyr, or Met for Leu at residue 118 of SEQ ID NO:
 1. 34. The mutant castor Δ⁹-18:0-ACP desaturase of claim 30 having an amino acid substitution of Ile for Pro at residue 179 of SEQ ID NO:
 1. 35. The mutant castor Δ⁹-18:0-ACP desaturase of claim 30 having an amino acid substitution of Ile for Thr at residue 181 of SEQ ID NO:
 1. 36. The mutant castor Δ⁹-18:0-ACP desaturase of claim 30 having an amino acid substitution of Leu for Gly at residue 188 of SEQ ID NO:
 1. 37. The mutant castor Δ⁹-18:0-ACP desaturase of claim 30 having an amino acid substitution of Ile for Met at residue 114 of SEQ ID NO: 1 and an amino acid substitution of Leu for Gly at residue 188 of SEQ ID NO:
 1. 38. A mutant 18:0-ACP desaturase which has a sufficiently elevated 14 carbon atom chain length substrate specificity, such that when introduced into an unsaturated fatty acid auxotroph cell said mutant desaturase permits growth of said unsaturated fatty acid auxotroph cell in an absence of supplemental unsaturated fatty acid.
 39. The mutant 18:0-ACP desaturase of claim 38 wherein the mutant 18:0-ACP desaturase is a mutant plant 18:0-ACP desaturase.
 40. The mutant plant 18:0 desaturase of claim 39 wherein the mutant plant 18:0-ACP desaturase is a mutant castor Δ⁹-18:0-ACP desaturase.
 41. The mutant castor Δ⁹-18:0-ACP desaturase of claim 40 having an amino acid substitution of Phe or Tyr for Met at residue
 114. 42. The mutant castor Δ⁹-18:0-ACP desaturase of claim 40 produced by an amino acid substitution of Leu for Pro at residue
 179. 43. A DNA expression construct comprising, in expressible form, a nucleic acid sequence encoding a mutant 18:0 desaturase which has a 16 carbon atom chain length substrate specificity.
 44. A DNA expression construct comprising, in expressible form, a nucleic acid sequence encoding a mutant castor Δ⁹-18:0-ACP desaturase which has a 16 carbon chain length substrate specificity.
 45. A DNA expression construct comprising, in expressible form, a nucleic acid sequence encoding a mutant 18:0 desaturase which has a 14 carbon atom chain length substrate specficity.
 46. A DNA expression construct comprising, in expressible form, a nucleic acid sequence encoding a mutant castor Δ⁹-18:0-ACP desaturase which has a 14-carbon atom chain length substrate specificity.
 47. A cell transformed with a DNA expression construct comprising, in expressible form, a nucleic acid sequence encoding a mutant 18:0 desaturase which has a 16 carbon atom chain length substrate specificity.
 48. The cell of claim 47 which is a prokaryotic cell.
 49. The cell of claim 47 which is a eukaryotic cell.
 50. The cell of claim 49 which is a plant cell.
 51. A cell transformed with a DNA expression construct comprising, in expressible form, a nucleic acid sequence encoding a mutant castor Δ⁹-18:0-ACP desaturase which has a 16-carbon atom chain length substrate specificity.
 52. The cell of claim 51 which is a prokaryotic cell.
 53. The cell of claim 51 which is a eukaryotic cell.
 54. The cell of claim 53 which is a plant cell.
 55. A cell transformed with a DNA expression construct comprising, in expressible form, a nucleic acid sequence encoding a mutant 18:0 desaturase which has a 14 carbon atom chain length substrate specificity.
 56. The cell of claim 55 which is a prokaryotic cell.
 57. The cell of claim 55 which is a eukaryotic cell.
 58. The cell of claim 57 which is a plant cell.
 59. A cell transformed with a DNA expression construct comprising, in expressible form, a nucleic acid sequence encoding a mutant castor Δ⁹-18:0-ACP desaturase which has a 14 carbon atom chain length substrate specificity.
 60. The cell of claim 59 which is a prokaryotic cell.
 61. The cell of claim 59 which is a eukaryotic cell.
 62. The cell of claim 61 which is a plant cell.
 63. A transgenic plant expressing a nucleic acid sequence encoding a mutant 18:0 desaturase which has a 16 carbon atom chain length substrate specificity.
 64. The transgenic plant of claim 63 which is Arabidopsis thaliana.
 65. A transgenic plant expressing a nucleic acid sequence encoding a mutant castor Δ⁹-18:0-ACP desaturase which has a 16 carbon atom chain length substrate specificity.
 66. The transgenic plant of claim 65 which is Arabidopsis thaliana.
 67. A transgenic plant expressing a nucleic acid sequence encoding a mutant 18:0 desaturase which has a 14 carbon atom chain length substrate specificity.
 68. The transgenic plant of claim 67 which is Arabidopsis thaliana.
 69. A transgenic plant expressing a nucleic acid sequence encoding a mutant castor Δ⁹-18:0-ACP desaturase which has a 14 carbon atom chain length substrate specificity.
 70. The transgenic plant of claim 69 which is Arabidopsis thaliana. 